WANBURY
|
The Current P/S Ratio of WANBURY is 1.22.
Share Price | ₹210.2 | Mar 13,2025 |
Market Cap | ₹689.5 Cr | |
Sales-TTM | ₹565.2 Cr | TTM-Consolidated Results |
Price/Sales | 1.22x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of WANBURY
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹689.5 Cr] as on Mar 13,2025
(/) Sales [ ₹565.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.22x ]
Thus, for WANBURY , the investors are currently willing to pay '1.22 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WANBURY !
The chart below summarizes the trend in P/S Ratio of WANBURY over the last five years.
Historical PS (Price/Sales) ratio chart of WANBURY
PS Ratio Performance Analysis for WANBURY
- WANBURY 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.45x.
- WANBURY 's operated at median p/e ratio of 0.53x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/e ratio peaked in Mar2024 at 0.83x.
- WANBURY 's p/e ratio hit its five-year low in Mar2020 of 0.12x.
How does WANBURY 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
WANBURY | 565.2 | 1.22 | 689.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 7.83 | 404,012.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 16.43 | 149,188.0 |
CIPLA LTD | 26,981.2 | 4.37 | 118,041.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.16 | 103,512.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 2.96 | 92,445.1 |
MANKIND PHARMA LTD | 11,641.0 | 7.80 | 90,812.7 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 3.99 | 88,805.2 |
LUPIN LTD | 22,001.6 | 4.09 | 89,895.2 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.06 | 63,577.4 |
ABBOTT INDIA LTD | 6,243.2 | 10.08 | 62,917.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WANBURY 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.22x |
Max industry PS | 16.43x |
Median industry PS | 4.37x |
Average industry PS | 6.36x |
You may also like the below Video Courses